Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Elisabeth-TweeSteden Ziekenhuis

Verified siteinfo

The Netherlands Hilvarenbeekse Weg 60, 5022 Tilburg, The Netherlands

  • 1 trial recruiting
  • Multiple sclerosis · Rheumatoid arthritis
  • Adult patients

About Specializations

Elisabeth-TweeSteden Ziekenhuis in Tilburg, The Netherlands specialises in clinical trials of conditions such as Multiple sclerosis, Rheumatoid arthritis, and other specialisations. This site conducts important research.

Main research areas of the site

Neurology and Multiple Sclerosis

The medical center is at the forefront of neurology research, with a particular focus on Multiple Sclerosis (MS). The institution is dedicated to exploring innovative treatment strategies that enhance patient outcomes and quality of life.

  • Personalized Treatment Approaches
  • Extended Interval Dosing
  • Real-life Cohort Studies

Through its pioneering work, the center is advancing the understanding of MS and developing personalized therapies that aim to improve the safety and efficacy of existing treatments.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Hilvarenbeekse Weg 605022 TilburgThe Netherlands
Open in maps ↗
Recruiting now
1 trial
Conditions studied
2
Partner status
Verified site

More sites in TilburgThe Netherlands

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Rheumatoid arthritis

Recruiting

Discontinuation of methotrexate (drug combination) in rheumatoid arthritis patients using TNF inhibitors

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Adalimumab
  • Sponsor:Sint Maartenskliniek Stichting

Multiple sclerosis

Not recruiting

Study on Personalized Dosing of Natalizumab for Patients with Relapsing-Remitting Multiple Sclerosis

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Natalizumab
  • Sponsor:Amsterdam UMC Stichting
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.